News & Events
Keep upto date with all the latest news and insights from Nanopharm.
-
-
Join us at InspireMe in San Francisco, June 4-5, 2019.
InspireMe promises to be the DPI and Soft Mist industry event of the year.
Read More -
Meet disruptive innovation at RDD Europe 2019
Nanopharm is creating value for our clients through disruptive innovation in respiratory product development.
Read More -
-
Nanopharm Announce Appointment of Head of Device Development
Device Development Established at Nanopharm Ltd
Read More -
Nanopharm Announces Appointment of Chairman
Nanopharm Announces the Appointment of Mark Clement as Chairman of the Board
Read More -
Addition of the Malvern G3-ID at Nanopharm
Demonstrating bioequivalence (BE) for complex generics such as nasal spray suspension drug products is a challenging task. Sponsors not only have to consider device requirements but also understand the properties of the API in the presence of functional excipients.
Read More -
New research into in vitro strategies for demonstrating bioequivalence in generic nasal sprays
Nanopharm Ltd, supported by Malvern instruments and with funding from the Food and Drug Administration (FDA), have carried out experimental studies to identify analytical strategies that can help bring generic nasal sprays to market faster.
Read More
